Cantor Fitzgerald Reiterates Intellia Therapeutics (NTLA) Overweight Recommendation
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Fintel reports that on August 29, 2023, Cantor Fitzgerald reiterated coverage of Intellia Therapeutics (NASDAQ:NTLA) with a Overweight recommendation.
:max_bytes(150000):strip_icc():format(jpeg)/counterfeiting-money-88622123-78b1bc18a7d4426ab5120d35637131c8.jpg "How to Spot Fake Money")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1152447561-147c6353f25941d78b65f64ef9dc447c.jpg "<div>Percentage of Completion vs. Completed Contract: What's the Difference?</div>")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1683553525-6de999cabb614c0982df9166e8248583.jpg "5 by 5 Power: What It Means, How It Works")